MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, today announced the signing of an agreement with C4 Therapeutics, Inc. to acquire an exclusive license for the Achilles-TAG (aTAG) degradation platform. The license will make aTAG technology commercially […]
As the first and only platform with these capabilities, the Tapestri Platform will enable key insights to drive the development of more impactful cancer therapies SOUTH SAN FRANCISCO, Calif. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced its expansion into single-cell multi-omics. The company’s proprietary technology, the […]
Madison, WI USA. Promega Corporation today announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite instability (MSI) technology as an on-label, solid tumor companion diagnostic (CDx) for use with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). The global collaboration will initially seek regulatory […]
Ion Torrent Genexus System* holds potential to advance precision medicine in the clinic BALTIMORE — Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow that delivers results economically in a single day. Launched at the Association for Molecular Pathology (AMP) 2019 annual […]
New Ionic™ Purification System produces higher yields of pure, ready-to-sequence nucleic acids in one hour with less than three minutes of hands-on time per sample BALTIMORE, MD – Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced the launch of its Ionic™ Purification System. The […]
Fluicell is incredibly proud to launch Biopixlar. Biopixlar is a breakthrough technology that we believe will be of great benefit to researchers and pharmaceutical companies. Please look at our video!
Portable TERRA™ II and Benchtop BTX™ III mobile XRD analyzers offer SwiftMin automated quantitative XRD software, a streamlined user interface, preprogrammed calibrations and an improved X-ray detector for increased productivity without the need for a technical expert. WALTHAM, Mass.—The Olympus next-generation TERRA™ II and BTX™ III mobile X-ray diffraction (XRD) analyzers offer faster quantitative mineralogy […]
ALPCO’s new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. Salem, NH — ALPCO, a leading developer and manufacturer of life science test solutions to advance research and improve clinical outcomes, announced the official launch […]
PALO ALTO, Calif. & SCHLIEREN, Switzerland– R&D services platform will make it easier for researchers throughout the world to purchase InSphero assay ready models and services for drug efficacy and safety testing Science Exchange, the world’s leading SaaS-enabled marketplace for outsourced R&D, and InSphero AG today announced a collaboration to facilitate access to InSphero’s comprehensive portfolio of […]
Mastermind Genomic Search Engine Now Filters Evidence by Phenotype – Critical for the Genetic Interpretation of Rare Diseases Genomenon® announced the release of Mastermind® version 2.0. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
